Literature DB >> 12563261

Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development.

Kaoru Saijo1, Christian Schmedt, I-Hsin Su, Hajime Karasuyama, Clifford A Lowell, Michael Reth, Takahiro Adachi, Alina Patke, Angela Santana, Alexander Tarakhovsky.   

Abstract

The nature of signals that govern the development of immunoglobulin heavy chain-dependent B cells is largely unknown. Using mice deficient for the B cell-expressed Src-family protein tyrosine kinases (SFKs) Blk, Fyn and Lyn, we show an essential role of these kinases in pre-B cell receptor (pre-BCR)- mediated NF-kappaB activation and B cell development. This signaling defect is SFK specific, as a deficiency in Syk, which controls pre-B cell development, does not affect NF-kappaB induction. Impaired NF-kappaB induction was overcome by the activation of protein kinase C (PKC)-lambda, thus suggesting the involvement of PKC-lambda in pre-BCR-mediated SFK-dependent activation of NF-kappaB. Our data show the existence of a functionally distinct SFK signaling module responsible for pre-BCR-mediated NF-kappaB activation and B cell development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12563261     DOI: 10.1038/ni893

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  114 in total

1.  Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection.

Authors:  Benoit Briard; Rajendra Karki; R K Subbarao Malireddi; Anannya Bhattacharya; David E Place; Jayadev Mavuluri; Jennifer L Peters; Peter Vogel; Masahiro Yamamoto; Thirumala-Devi Kanneganti
Journal:  Nat Microbiol       Date:  2018-12-03       Impact factor: 17.745

Review 2.  Emerging and diverse roles of protein kinase C in immune cell signalling.

Authors:  Seng-Lai Tan; Peter J Parker
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

3.  The role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells.

Authors:  Anastasia Nijnik; Jelena Pistolic; Patricia Cho; Niall C J Filewod; Reza Falsafi; Alexander Ramin; Kenneth W Harder; Robert E W Hancock
Journal:  J Leukoc Biol       Date:  2012-01-13       Impact factor: 4.962

Review 4.  Unraveling the genetic component of systemic sclerosis.

Authors:  José Ezequiel Martín; Lara Bossini-Castillo; Javier Martín
Journal:  Hum Genet       Date:  2012-01-05       Impact factor: 4.132

5.  Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellin.

Authors:  Anastasia Nijnik; Jelena Pistolic; Niall C J Filewod; Robert E W Hancock
Journal:  J Innate Immun       Date:  2012-04-17       Impact factor: 7.349

Review 6.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

Review 7.  Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.

Authors:  Markus Müschen
Journal:  Blood       Date:  2015-04-15       Impact factor: 22.113

Review 8.  Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.

Authors:  Maike Buchner; Markus Müschen
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

9.  Variants in TNFSF4, TNFAIP3, TNIP1, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population.

Authors:  Xian-Bo Zuo; Yu-Jun Sheng; Su-Juan Hu; Jin-Ping Gao; Yang Li; Hua-Yang Tang; Xian-Fa Tang; Hui Cheng; Xian-Yong Yin; Lei-Lei Wen; Liang-Dan Sun; Sen Yang; Yong Cui; Xue-Jun Zhang
Journal:  Rheumatol Int       Date:  2013-10-04       Impact factor: 2.631

Review 10.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.